Skip to content

Effect of shoulder joint fluid injection on Recovery in frozen shoulder.A comparison between primary adhesive capsulitis and in post breast cancer patients.

Impact of Glenohumeral joint Hydrodilatation on functional recovery in primary versus post breast cancer adhesive capsulitis. A prospective comparative trail. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102155
Enrollment
64
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M60-M63- Disorders of muscles

Interventions

Intervention1: Glenohumeral joint hydrodilatation: All participants with idiopathic adhesive capsulitis who have not responded to conservative management, undergo ultrasound guided suprascapular nerv

Sponsors

All India Institute Of Medical Sciences Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 65 years. 2. Clinical diagnosis of adhesive capsulitis with Significant restriction in passive ROM of the shoulder joint. 3. Shoulder pain VAS score greater than or equal to 5 that exacerbated by movement. 4. Symptoms persisted for at least three months. 5. Diagnosis of breast cancer and completed definitive treatment

Exclusion criteria

Exclusion criteria: 1.Systemic or structural disorders that could result in limited ROM or pain, such as major trauma, shoulder surgical history, rotator cuff tear, or inflammatory joint disease. 2.Male patients and patients with stage IV breast cancer 3.Neurological conditions affecting the upper limb (e.g., stroke, brachial plexopathy, Radiculopathy). 4.Radiographically significant pathology in shoulder except mild osteopenia 5.Known allergy to local anaesthetics or steroids. 6.Coagulopathy, current anticoagulant therapy, or local skin infection at injection site. 7. Inability to comply with rehabilitation protocol due to physical or cognitive limitation. 8.Active breast cancer under current treatment. 9.Severe cognitive impairment or psychiatric illness interfering with consent or follow-up 10. Refusal to provide informed consent or non-compliance with follow-up schedule

Design outcomes

Primary

MeasureTime frame
evaluate the effectiveness of glenohumeral joint hydrodilatation in improving SPADI scores in patients with treatment-resistant primary adhesive capsulitis and secondary adhesive capsulitis following breast cancer treatment, both after failure of conservative management.Timepoint: baseline, 1, 3, and 6 months

Secondary

MeasureTime frame
To assess changes in pain (Visual analogue scale).Timepoint: baseline, 1, 3, and 6 months;To assess changes in Range of motionTimepoint: baseline, 1, 3, and 6 months;To assess the change in quality of life using SF-12Timepoint: baseline, 1, 3, and 6 months;To compare recovery timelines between groupsTimepoint: baseline, 1, 3, and 6 months;To determine the prevalence and characteristics of ipsilateral shoulder dyskinesia.Timepoint: baseline, 1, 3, and 6 months;To compare the effect of postsurgical scar length on change shoulder ROMTimepoint: baseline, 1, 3, and 6 months;To evaluate rehabilitation participation post-intervention. STUDYTimepoint: baseline, 1, 3, and 6 months

Countries

India

Contacts

Public ContactDr Ravi Gaur

All India Institute Of Medical Sciences, Jodhpur

gaurravi@gmail.com829971153

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026